Target Name: MIR7847
NCBI ID: G102465993
Review Report on MIR7847 Target / Biomarker Content of Review Report on MIR7847 Target / Biomarker
MIR7847
Other Name(s): hsa-mir-7847 | hsa-miR-7847-3p | microRNA 7847 | MicroRNA 7847

MIR7847: A drug target and biomarker for cancer treatment

MIR7847 is a drug target and a biomarker that is being studied for its potential in treating various diseases, including cancer. MIR7847 is a small interleukin-7 receptor antagonist that blocks the activity of the IL-7 receptor, which is involved in the regulation of immune and inflammatory responses.

The IL-7 receptor is a protein that is found on the surface of immune cells, including T cells, which are responsible for fighting off infections and cancer. When the IL-7 receptor is activated, it can cause the immune system to become too active and start attacking the body, which can lead to the development of autoimmune diseases and cancer.

MIR7847 works by blocking the activity of the IL-7 receptor, which can help to reduce the activity of the immune system and prevent the development of autoimmune diseases. In addition, MIR7847 has also been shown to have anti-inflammatory effects, which can help to reduce the risk of the development of inflammatory diseases.

MIR7847 is currently being studied for its potential in treating various diseases, including cancer. Studies have shown that MIR7847 can be effective in slowing the growth of cancer cells and reducing the spread of cancer to other parts of the body. In addition, MIR7847 has also been shown to improve the quality of life for people with cancer by reducing the symptoms of pain and anxiety.

In addition to its potential as a cancer treatment, MIR7847 is also being studied for its potential as a biomarker. Biomarkers are substances that are produced by the body that can be used as indicators of the presence of a particular disease or condition.

MIR7847 has been shown to be a potential biomarker for several types of cancer, including breast, lung, and ovarian cancer. Studies have shown that MIR7847 can be detected in the bloodstream and have been associated with the development of these cancers. In addition, MIR7847 has also been shown to be a potential biomarker for autoimmune diseases, such as rheumatoid arthritis and lupus.

In conclusion, MIR7847 is a drug target and biomarker that has the potential to improve the treatment of various diseases, including cancer. Studies have shown that MIR7847 can be effective in slowing the growth of cancer cells and reducing the spread of cancer to other parts of the body. In addition, MIR7847 has also been shown to improve the quality of life for people with cancer by reducing the symptoms of pain and anxiety. Further research is needed to determine the full potential of MIR7847 as a cancer treatment and biomarker.

Protein Name: MicroRNA 7847

The "MIR7847 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR7847 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR7848 | MIR7849 | MIR7850 | MIR7851 | MIR7854 | MIR7855 | MIR7856 | MIR7974 | MIR7975 | MIR7976 | MIR7977 | MIR802 | MIR8054 | MIR8055 | MIR8059 | MIR8060 | MIR8061 | MIR8063 | MIR8064 | MIR8067 | MIR8069-1 | MIR8070 | MIR8071-1 | MIR8071-2 | MIR8072 | MIR8073 | MIR8075 | MIR8076 | MIR8078 | MIR8080 | MIR8082 | MIR8084 | MIR8085 | MIR8087 | MIR8088 | MIR8089 | MIR8485 | MIR873 | MIR874 | MIR875 | MIR876 | MIR877 | MIR885 | MIR887 | MIR888 | MIR889 | MIR890 | MIR891A | MIR891B | MIR892A | MIR892B | MIR892C | MIR9-1 | MIR9-1HG | MIR9-2 | MIR9-3 | MIR9-3HG | MIR920 | MIR921 | MIR922 | MIR924 | MIR924HG | MIR92A1 | MIR92A2 | MIR92B | MIR93 | MIR933 | MIR934 | MIR935 | MIR936 | MIR937 | MIR938 | MIR939 | MIR940 | MIR941-1 | MIR941-2 | MIR941-3 | MIR941-4 | MIR941-5 | MIR942 | MIR943 | MIR944 | MIR95 | MIR96 | MIR98 | MIR99A | MIR99AHG | MIR99B | MIRLET7 | MIRLET7A1 | MIRLET7A2 | MIRLET7A3 | MIRLET7B | MIRLET7BHG | MIRLET7C | MIRLET7D | MIRLET7E | MIRLET7F1 | MIRLET7F2 | MIRLET7G